
CANARITECH is a leading Contract Research Organization (CRO) focused on delivering high-quality clinical research and regulatory solutions across Latin America. We combine global standards with deep regional expertise to support pharmaceutical, biotechnology, and medical device companies at every stage of development.
Our team works closely with clients to ensure clarity, compliance, and efficient execution—transforming scientific challenges into actionable results.
Use the form below to contact our team and start a conversation about your project.

Pharmaceutical development costs $2.6B per drug on average. Trials take 10+ years. And 80% of studies fail to recruit diverse patient populations in time. The system is broken — and it’s killing innovation.

We connect Latin American science with global regulation, capital, and markets. 30–60% lower cost. Faster recruitment. Genetically diverse populations. And an AI-powered platform that turns research into real, scalable business.
We didn't start in tech. We started in pharmaceutical development — where a missed signal doesn't mean a bug report. It means lives. That obsession with early detection, rigorous validation, and intelligent redundancy is our true foundation.
We don't sell hours. We don't build generic solutions. We identify critical opportunities in science and technology, structure them, validate them, and turn them into real, scalable business.
Tell us who you are and we'll show you exactly how Canaritech can work for you.

Canaritech proved to be the ideal partner for expanding our studies across Latin America. Their in-depth knowledge of country-specific regulations and their well-structured operational network made all the difference. Our three-country clinical trial was executed without delays and delivered with flawless reporting. Communication was consistent, clear, and highly professional.

CEO, MedLabTech (Chile)

Canaritech played a key role in validating our medical technology in record time. As a startup, we needed clear guidance and hands-on support throughout the entire regulatory process, and they exceeded our expectations. Their approach is highly human-centered while remaining technically precise. They helped us translate our innovation into solid clinical evidence.

Director of Clinical Operations, FarmaLink LATAM





